TAIPEI, TAIWAN – Media OutReach Newswire – 16 August 2025 – Lung cancer continues to be the leading cause of cancer-related deaths worldwide. Yet, progress is within reach. In Taiwan, thanks to the National Lung Cancer Early Detection Program, the proportion of early-stage lung cancer cases continues to rise. Against this backdrop, HOPE Foundation for Cancer Care, one of the largest cancer-focused patient advocacy groups in Taiwan, recently hosted a press conference titled “Healthy Taiwan, Leading the World – Ushering in a New Era of Early Screening and treatment of Lung Cancer”. The event brought together distinguished government officials, ten leading medical authorities in lung cancer, and renowned lung cancer experts from major medical centers nationwide to chart the next phase of early lung cancer prevention and control policies. United in their commitment, participants advocated for the seamless integration of early screening, precision diagnostics, and early treatment in lung cancer care, strengthening efforts to promote early detection and intervention. Ultimately, aiming to support Taiwan in achieving its ambitious goal of reducing cancer mortality rates by one-third by 2030, setting a new international benchmark in cancer control.

Taiwan’s proactive approach to lung cancer prevention is recognized globally for its vision and effectiveness. In July 2022, the government launched the Lung Cancer Early Detection Program, offering biannual low-dose CT (LDCT) screenings for high-risk groups, including those with a family history of lung cancer and heavy smokers. This pioneering initiative has positioned Taiwan as an international role model in lung cancer prevention. Over the past three years, more than 210,000 screenings have led to the identification of 2,506 lung cancer cases—over 80% of which were diagnosed at an early stage, with late-stage diagnoses dropping sevenfold. Previously, late-stage diagnosis was the norm, but Taiwan’s proactive policies have transformed the landscape, reversing the trend and ensuring that most initial lung cancer cases are now detected early.

During his recent visit to Taiwan, Dr. Cary Adams, CEO of the Union for International Cancer Control (UICC), commended Taiwan’s National Cancer Control Program, its comprehensive cancer registry, and robust National Health Insurance (NHI) system for establishing an exemplary cancer care network. He encouraged Taiwan to further improve early lung cancer screening rates and timely access to treatment, reinforcing its status as a global public health leader. At the conference, Minister of Health and Welfare Dr. Chiu Tai-Yuan pledged ongoing cross-ministerial collaboration and policy innovation to improve early lung cancer detection and treatment. Legislator Wang Cheng-Hsu also reaffirmed his commitment to early detection and intervention, advocating for increased resources and improved legislation to ensure early-stage lung cancer patients receive comprehensive care.

Leading medical experts further emphasized Taiwan’s advancements. Dr. Yang, Pan-Chyr, Academician of Academia Sinica, highlighted how the LDCT screening program has driven a shift toward earlier-stage diagnosis, with research indicating it could reduce lung cancer mortality by 53%. Dr. Chen Chien-Jen, Academician of Academia Sinica emphasized that the next key challenge is ensuring early-stage patients benefit from precision diagnostics and early treatment. Dr. Yang Cheng-Ta, President of the Taiwan Lung Cancer Society, added that emerging AI technology is now capable of analyzing LDCT images to predict an individual’s six-year cancer risk, which will improve identification of high-risk groups and support early intervention. Dr. Yang Chih-Hsin, President of Taiwan Association for the Study of Lung Cancer, urged early-stage patients to undergo genetic testing promptly, enabling medical teams to tailor optimal treatment plans, including surgery, targeted therapy, or immunotherapy as adjuvant treatments.

HOPE called for NHI resources to shift toward early lung cancer diagnosis and treatment, highlighting the importance of genetic testing and adjuvant therapy for high-risk early-stage patients to reduce relapse and mortality. Clinical evidence shows that adjuvant targeted therapy after surgery for stage IB–IIIA lung cancer with EGFR mutations can reduce five-year mortality by 10%, which is vital for improving outcomes and easing the burden on the healthcare system. Dr. Chen Jin-Shing, Head of Thoracic Surgery Division at National Taiwan University Hospital, advocated for priority reimbursement of adjuvant targeted therapy for patients with stage IB-IIIA lung cancer, while Dr. Chen Chih-Yi, Board Member of HOPE emphasized the importance of improving access to early genetic testing and treatment. Dr. Huang, Ming-Shyan, President of the Taiwan Clinical Oncology Society, pointed out that early-stage lung cancer treatment in Taiwan is not yet fully aligned with international guidelines, and urged that expanded screening must be matched with optimized NHI resource allocation and improved treatment access.

Other leading voices reinforced the need for comprehensive care. Dr. Wang Chin-Chou, Board Member of Taiwan Society of Pulmonary and Critical Care Medicine, stressed that while surgery is the primary treatment for early-stage lung cancer, it must be accompanied by proactive adjuvant therapy strategies and long-term follow-up. Dr. Chang Wen-Cheng, CEO of Taiwan Cancer Foundation emphasized that the integration of screening, diagnosis, and treatment is crucial to truly realize early detection and treatment, as well as maximizing the value of screening program. Dr. Chen Jen-Shi, President of Taiwan Oncology Society, recommended that in addition to current NHI and Cancer Drug Fund financing, the government should promote diverse payment mechanisms—such as co-payment models or commercial insurance to supplement the NHI system—to further improve access to early lung cancer treatment.

Uniting multiple lung cancer treatment experts from medical centers across Taiwan, a concerted effort to usher in a new era of early lung cancer screening and treatment. (Listed by institution from North to South)
· Dr. Chen Yu-Min, Director of General Chest Medicine Department, Taipei Veterans General Hospital
· Dr. Lee Kang-Yun, Attending Physician, Division of Pulmonary Medicine, Shuang Ho Hospital
· Dr. Huang Chun-Yao, Attending Physician, Division of Chest Medicine, Taipei Tzu Chi Hospital
· Dr. Tsai Chen-Liang, Director of Pulmonary and Critical Care Medicine Division, Tri-Service General Hospital
· Dr. Yeh Yu-Wen, Physician, Division of Thoracic Medicine, Shin Kong Wu Ho-Su Memorial Hospital
· Dr. Chang Sheng-Yu, Attending Physician and Leader of the Lung Cancer Team, Far Eastern Memorial Hospital
· Dr. Yang Tsung-Ying, Director of General Chest Medicine Department, Taichung Veterans General Hospital
· Dr. Hsia Te-Chun, Deputy Director, Department of Internal Medicine, China Medical University Hospital
· Dr. Lin Chien-Chung, Attending Physician, Division of Chest Medicine, National Cheng Kung University Hospital

Hashtag: #HOPEFoundation

The issuer is solely responsible for the content of this announcement.

Iracemápolis, São Paulo – Media OutReach Newswire – 16 August 2025 – In the early hours of August 16 (Beijing time), GWM’s Brazil plant officially commenced operations, marked by a grand ceremony for the rollout of its first vehicle, the HAVAL H6 GT. The plant, located in Iracemápolis, São Paulo, was acquired from Daimler Group and has since been upgraded into an intelligent manufacturing base. As GWM’s third full-process vehicle manufacturing center overseas, it carries the core mission of serving the Latin American market and acts as a key hub linking Europe, Asia, Southeast Asia, and Latin America.

This milestone not only advances GWM’s globalization in Latin America but also sets an example of China’s high-quality automotive expansion, showcasing innovative collaboration between the Chinese and Brazilian auto industries.

At the opening ceremony, Brazilian President Luiz Inácio Lula da Silva, Vice President Geraldo Alckmin, Chinese Ambassador Zhu Qingqiao, Brazil’s Minister of Labor, and other dignitaries joined GWM President Mu Feng, GWM International President Parker Shi, GWM Brazil Region President Zhang Gengshen, and other GWM executives to witness this landmark moment in the company’s globalization journey. President Lula personally signed the hood of the first HAVAL H6 GT, marking its final production step before entering the market. After the ceremony, he also posed for photos with factory workers.

In his welcome address, GWM President Mu Feng stated: “The Brazil plant is not only a strong commitment to the Brazilian market, but also the starting point for building the future together with our Latin American partners. In our global expansion, we adhere to the ‘Four New Modernizations’: Locally Built, Locally Operated, Globally Cultivated, Supply Chain Integrated. Following international quality standards, we will deliver highly reliable vehicles to the Latin American market.” He further announced that the plant’s annual production capacity will gradually increase from 20,000 to 50,000 vehicles, creating over 1,000 direct jobs. Initial models include the HAVAL H9, POER P30, and HAVAL H6, with the H9 and POER P30 scheduled to launch in Brazil this September.

Chinese Ambassador Zhu Qingqiao emphasized that since the establishment of diplomatic ties 51 years ago, China and Brazil’s comprehensive strategic partnership has continued to deepen, with key areas of cooperation including renewable energy, infrastructure, and manufacturing. He described the Brazil plant as a model of Sino-Brazilian industrial synergy, combining “Chinese smart manufacturing + Brazilian localization.” He noted that GWM is contributing to economic development and quality job creation in São Paulo and Brazil, and expressed hope for further collaboration in clean energy and digital technology to provide a “China-Brazil solution” for global climate governance.

In his speech, President Lula stressed: “The GWM Brazil plant is very important for Brazil’s national industry. Its inauguration shows that Brazil has the capability to acquire advanced technology and produce vehicles that can compete with those from any country in the world. This means creating jobs, increasing income, and enhancing professional expertise for Brazilians. We hope GWM will make Brazil its production base in Latin America. The Brazilian government stands ready to support businesses and welcomes more Chinese companies to invest here.”

Brazilian Vice President Alckmin, the Minister of Labor, and the Mayor of Iracemápolis also gave speeches, jointly opening a new chapter for GWM in Latin America. Guests at the ceremony praised GWM’s rapid growth and contributions to Brazil’s automotive market and expressed confidence in the company’s ability to further drive innovation and transformation in the industry. During the event, the Great Place to Work Institute awarded GWM Brazil the “Great Place To Work” (GPTW) honor. In addition, GWM announced a donation of 500,000 reais to local schools in Iracemápolis to help improve educational facilities.

Located in Iracemápolis, São Paulo, the GWM Brazil plant covers a total area of 1.2 million square meters, with 94,000 square meters of built-up area. It houses welding workshops, robotic painting lines, assembly lines, energy and equipment facilities, and logistics supply systems. With an initial annual production capacity of 50,000 vehicles, the plant is expected to create 1,000 jobs by the end of this year. Initial models will include the HAVAL H9, POER P30, and the HAVAL H6 series. The plant also supports flexible production of multiple energy types, including hybrid (HEV), plug-in hybrid (PHEV), and diesel.

Since entering the Brazilian market in 2021, GWM has reached annual sales of 29,000 units within just three years, ranking 14th in the market. In the first half of this year, GWM sold over 15,700 vehicles in Brazil, up 19.8% year-on-year—17 percentage points above the industry average—demonstrating the company’s confidence and determination to expand overseas and compete globally.

Rooted in Brazil, expanding across Latin America, and reaching the world, GWM will continue to invest in Brazil, focusing on quality jobs, technological leadership, and R&D. The opening of the Brazil plant marks a new chapter in Chinese automotive globalization. With this plant, GWM will strengthen localized smart manufacturing, deepen its presence in Latin America, and bring its products and services to more global markets.

Hashtag: #GWM

The issuer is solely responsible for the content of this announcement.

– Public funds and public welfare capital accelerate circular technology –

DÜSSELDORF/BERLIN – Newsaktuell – 15 August 2025 – The non-profit cooldown°earth foundation congratulates its portfolio company matterr on receiving funding confirmation from the state of North Rhine-Westphalia as part of the EFRE/JTF program “Produktives.NRW.” Minister of Economic Affairs and Climate Protection Mona Neubaur presented the funding approval on August 6 in Düsseldorf.

To help end the export of waste from industrialised nations—a practice that currently places a disproportionate burden on the world’s poorest countries—matterr has developed a globally patented solution capable of repeatedly transforming waste back into high-quality raw materials.

With this funding, matterr can accelerate the construction of its second plant, now on a small industrial scale, in North Rhine-Westphalia. The core technology is the depolymerization of PET under mild conditions. This allows mixed waste such as multi-layer packaging or mixed textile fabrics to be broken down into their primary components and fossil raw materials to be replaced on a large scale. By returning the monomer-based process to primary material quality, it enables molecular upcycling: Polyester textiles, which previously could only be recycled for low-quality applications, are now being used to create products of the highest quality – not only new textiles, but even packaging that is approved for food contact.

“This is a unique partnership,” says Wolfgang K. Hoever, founder of cooldown°earth. “A charitable foundation takes the lead, the state follows – and the result is infrastructure that turns hard-to-recycle waste into a circular GreenTech product. This is great news for climate protection and for our region as a business location.”

The funding commitment awarded to matterr is not only the first from this programme but also the maximum possible grant amount of €30 million. The planned NRW facility is scheduled to start operations in 2027 with an annual capacity of 10,000 tonnes.

cooldown°earth is not the recipient of the funding, but an early investor and enabler. Any potential returns from its stake will, in accordance with its statutes, be reinvested in non-profit climate and environmental protection projects.

Background

• The State of NRW and the EU support strategic technologies under the Produktives.NRW (EFRE/JTF 2021–2027) programme to ensure they remain in NRW/Europe. The first grants went to, among others, matterr (“revolPET plant”) and Greenlyte. Minister Neubaur highlighted the triple benefit for climate, jobs and innovation. (Pressrelease NRW)
• matterr’s own statement details the funding amount, schedule and process; the plant will replace fossil-based PET feedstock with primary-quality recycled material. (Pressrelease matterr)

Hashtag: #cooldown°earth

The issuer is solely responsible for the content of this announcement.

About cooldown°earth:

The cooldown°earth foundation is a private, non-profit foundation based in Krefeld, Germany. Founded in 2013 by Dr. Annekathrin Edelmann and Wolfgang K. Hoever, it works to promote social cohesion and climate protection.

Projects include the Digital Climate School, which helps schools integrate education for sustainable development into their curricula. The foundation fosters skills in using new technologies for sustainability and strengthens motivation for the responsible use of the planet’s natural resources. www.cooldown.earth